Swedbank’s Neurocrine Biosciences NBIX Stock Holding History

Swedbank’s Portfolio NBIX Stock Details NBIX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$110M	Buy	651,082 +71,653	+12%	+$10.6M	0.09%	156
2026 Q1	$76.3M	Sell	579,429 -4,700	-0.8%	-$624K	0.08%	181
2025 Q4	$82.8M	Buy	584,129 +36,800	+7%	+$5.33M	0.08%	174
2025 Q3	$76.8M	Buy	547,329 +43,827	+9%	+$5.94M	0.08%	178
2025 Q2	$63.3M	Buy	503,502 +73,805	+17%	+$8.46M	0.07%	196
2025 Q1	$47.5M	Buy	429,697 +421,400	+5,079%	+$53.4M	0.06%	213
2024 Q4	$1.13M	Sell	8,297 -5,715	-41%	-$707K	﹤0.01%	649
2024 Q3	$1.61M	Hold	14,012	–	–	﹤0.01%	627
2024 Q2	$1.93M	Hold	14,012	–	–	﹤0.01%	612
2024 Q1	$1.93M	Buy	14,012 +6,768	+93%	+$924K	0.02%	474
2023 Q4	$954K	Hold	7,244	–	–	﹤0.01%	639
2023 Q3	$815K	Hold	7,244	–	–	﹤0.01%	632
2023 Q2	$683K	Hold	7,244	–	–	﹤0.01%	651
2023 Q1	$733K	Hold	7,244	–	–	﹤0.01%	652
2022 Q4	$865K	Hold	7,244	–	–	﹤0.01%	633
2022 Q3	$769K	Hold	7,244	–	–	﹤0.01%	654
2022 Q2	$706K	Hold	7,244	–	–	﹤0.01%	670
2022 Q1	$679K	Hold	7,244	–	–	﹤0.01%	700
2021 Q4	$613K	Hold	7,244	–	–	﹤0.01%	719
2021 Q3	$695K	Hold	7,244	–	–	﹤0.01%	706
2021 Q2	$705K	Hold	7,244	–	–	﹤0.01%	706
2021 Q1	$704K	Buy	+7,244	New	+$760K	﹤0.01%	699

Other funds holding NBIX

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

PBBUPS

PKO BP Bankowy Universal Pension Society Warsaw, Poland $350M AUM 272.18% 1-Year Est. Return

Aware Super Sydney, Australia $7.06B AUM

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Retirement Systems of Alabama Montgomery, Alabama $33.2B AUM 38.15% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

CAM

Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

FAF

Fjarde Ap-fonden Stockholm, Sweden $20.9B AUM 36.93% 1-Year Est. Return

Swedbank's NBIX Position: Q2 2026 in Review

Swedbank increased its Neurocrine Biosciences (NBIX) stake by 12% in Q2 2026, buying an estimated $10.6M and bringing the position to 651,082 shares worth $110M. The position accounts for 0.09% of the portfolio, ranked #156.

Swedbank first reported a position in NBIX in Q1 2021 and has held it in 22 quarters since. 223 funds tracked by Wall St. Rank hold NBIX as of Q2 2026.

Swedbank held 651,082 shares of Neurocrine Biosciences worth $110M as of Q2 2026.
Swedbank bought 71,653 Neurocrine Biosciences shares in Q2 2026, an estimated $10.6M.
Neurocrine Biosciences made up 0.09% of Swedbank's portfolio in Q2 2026, its #156 holding.
Swedbank first reported a position in Neurocrine Biosciences in Q1 2021 and has held it in 22 quarters since.
223 funds tracked by Wall St. Rank held Neurocrine Biosciences as of Q2 2026.

Based on Swedbank's 13F filing for Q2 2026, filed 15 Jul 2026.